← Leaderboards
Ignacio E. Sanz
University Of Rochester
$71,521,451
Attributed
$73,607,794
Total exposure
44
Grants
39
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $39.3M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$193,100,299 · 49
By mechanism
U19$112,662,513 · 15
P01$50,317,038 · 16
U54$12,827,242 · 6
R01$11,779,336 · 6
R37$3,732,908 · 1
R21$1,007,466 · 2
Top collaborators
- Kavita Dhodapkar9 shared
- Madhav V Dhodapkar7 shared
Most similar at University Of Rochester
Same institution · by research overlap
- David I Yule$18,067,834
- James E Melvin$15,081,375
- Ted B Begenisich$2,891,015
- Trevor J. Shuttleworth$8,118,663
- Keith W Nehrke$7,086,980
Others in their field
Top investigators on “B-Lymphocytes”
- Barton F Haynes · Duke University$400,419,833
- Lawrence Corey · Fred Hutchinson Cancer Center$83,920,398
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
- Dan H. Barouch · Fred Hutchinson Cancer Center$66,039,430
- Dennis R. Burton · Scripps Research Institute$63,566,673
- Rafi Ahmed · Emory University$62,743,001
Research focus
B-LymphocytesSystemic Lupus ErythematosusCellsAutoimmunityAutoimmune DiseasesRegulationMolecularResponseProgramsBaseAntibodiesT-LymphocytePlasma CellsEpigenetic ProcessMemoryResearch PersonnelFundingAutoreactivityAntigensDesignPathway InteractionsPathogenicityEnsureAutoreactive B Cell
Grant awards (191)
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$4,394,852
U19 · FY2025 · AI · contact PI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$3,653,748
U19 · FY2025 · AI · contact PI
Plasma Cells in Health and Disease$2,684,918
P01 · FY2025 · AI · contact PI
Project-002$753,898
P01 · FY2025 · AI · contact PI
Project-005$484,854
P01 · FY2025 · AI · contact PI
Project-003$475,722
P01 · FY2025 · AI · contact PI
Project 4$462,148
P01 · FY2025 · AI · contact PI
Core-001$416,823
P01 · FY2025 · AI · contact PI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$313,000
U19 · FY2025 · AI · contact PI
Admin-Core-001$91,473
P01 · FY2025 · AI · contact PI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$78,250
U19 · FY2025 · AI · contact PI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$4,394,852
U19 · FY2024 · AI · contact PI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$3,653,750
U19 · FY2024 · AI · contact PI
Plasma Cells in Health and Disease$2,686,806
P01 · FY2024 · AI · contact PI
Administrative Supplement for Emory SeroNet "Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity"$622,147
U54 · FY2024 · CA · contact PI
Project-005$545,050
P01 · FY2024 · AI · contact PI
Project-002$536,066
P01 · FY2024 · AI · contact PI
Project-003$516,450
P01 · FY2024 · AI · contact PI
Project 4$516,450
P01 · FY2024 · AI · contact PI
Core-001$469,500
P01 · FY2024 · AI · contact PI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$234,750
U19 · FY2024 · AI · contact PI
Regulation of B cell Responses in SLE and Other Autoimmune Diseases$193,354
U19 · FY2024 · AI · contact PI
Admin-Core-001$135,164
P01 · FY2024 · AI · contact PI
Plasma Cells in Health and Disease$135,164
P01 · FY2024 · AI · contact PI
Admin-Core-001$103,290
P01 · FY2024 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$88,879
U54 · FY2024 · CA · contact PI
Project-004$88,878
U54 · FY2024 · CA · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$88,878
U54 · FY2024 · CA · contact PI
Molecular Regulation of B cells and T cells in Human SLE$6,250,527
U19 · FY2023 · AI · contact PI
ACE Funds Management Core$5,785,751
U19 · FY2023 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$3,057,531
U54 · FY2023 · CA · contact PI
Plasma Cells in Health and Disease$2,691,282
P01 · FY2023 · AI · contact PI
Project 1$536,066
P01 · FY2023 · AI · contact PI
Project 4$525,722
P01 · FY2023 · AI · contact PI
B cells in autoimmunity following checkpoint blockade therapy$440,314
R01 · FY2023 · CA
Project-002$406,974
U19 · FY2023 · AI · contact PI
B cell depletion to prevent autoimmunity$393,969
R01 · FY2023 · AR
Administrative Core$101,791
P01 · FY2023 · AI · contact PI
Administrative Core$57,802
U19 · FY2023 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$4,808,545
U19 · FY2022 · AI · contact PI
ACE Funds Management Core$4,525,024
U19 · FY2022 · AI · contact PI
Plasma Cells in Health and Disease$2,695,938
P01 · FY2022 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$1,995,375
U54 · FY2022 · CA · contact PI
Project 1$550,191
P01 · FY2022 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$545,091
U54 · FY2022 · CA · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$545,091
U54 · FY2022 · CA · contact PI
Project 4$541,971
P01 · FY2022 · AI · contact PI
B cells in autoimmunity following checkpoint blockade therapy$445,267
R01 · FY2022 · CA
B cell depletion to prevent autoimmunity$397,099
R01 · FY2022 · AR
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$359,168
U54 · FY2022 · CA · contact PI
Project-002$206,516
U19 · FY2022 · AI · contact PI
Project-004$199,538
U54 · FY2022 · CA · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$159,630
U54 · FY2022 · CA · contact PI
Administrative Core$101,791
P01 · FY2022 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$88,782
U19 · FY2022 · AI · contact PI
Administrative Core$77,005
U19 · FY2022 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$46,256
U19 · FY2022 · AI · contact PI
ACE Covid 19 Admin Supplement: Molecular Regulation of B cells and T cells in Human SLE$26,794,157
U19 · FY2021 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$5,901,416
U19 · FY2021 · AI · contact PI
ACE Funds Management Core$3,039,348
U19 · FY2021 · AI · contact PI
Administrative Core$653,143
U19 · FY2021 · AI · contact PI
Project-002$560,943
U19 · FY2021 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$560,943
U19 · FY2021 · AI · contact PI
B cells in autoimmunity following checkpoint blockade therapy$465,730
R01 · FY2021 · CA
B cell depletion to prevent autoimmunity$396,705
R01 · FY2021 · AR
Molecular Regulation of B cells and T cells in Human SLE$374,678
U19 · FY2021 · AI · contact PI
Project-002$254,427
U19 · FY2021 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$171,686
U19 · FY2021 · AI · contact PI
ACE Funds Management Core$171,686
U19 · FY2021 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$5,067,462
U19 · FY2020 · AI · contact PI
ACE Funds Management Core$4,639,204
U19 · FY2020 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$3,963,391
U54 · FY2020 · CA · contact PI
Plasma Cells in Health and Disease$2,025,932
P01 · FY2020 · AI · contact PI
Regulation of Pathogenic Plasma Cells in Human SLE$1,747,765
P01 · FY2020 · AI · contact PI
Plasma Cells in Health and Disease$1,747,765
P01 · FY2020 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$1,124,031
U19 · FY2020 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$795,460
U54 · FY2020 · CA · contact PI
Administrative Supplement Covid19: Molecular Regulation of B cells and T cells in Human SLE$525,608
U19 · FY2020 · AI · contact PI
Principal Project$525,608
U19 · FY2020 · AI · contact PI
B cells in autoimmunity following checkpoint blockade therapy$465,726
R01 · FY2020 · CA
B cell depletion to prevent autoimmunity$411,840
R01 · FY2020 · AR
Promoting the Development of Epigenetically and Functionally Distinct Plasma Cell Populations by Modulating the Cytokine Microenvironment$397,970
P01 · FY2020 · AI · contact PI
Regulation of Pathogenic Plasma Cells in Human SLE$392,476
P01 · FY2020 · AI · contact PI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity$318,185
U54 · FY2020 · CA · contact PI
Project-002$116,799
U19 · FY2020 · AI · contact PI
Core A - Administrative Core$83,504
P01 · FY2020 · AI · contact PI
Administrative Core$77,865
U19 · FY2020 · AI · contact PI
Molecular Regulation of B cells and T cells in Human SLE$5,194,108
U19 · FY2019 · AI · contact PI
Administrative Core$4,377,647
U19 · FY2019 · AI · contact PI
Plasma Cells in Health and Disease$2,026,518
P01 · FY2019 · AI · contact PI
B cells in autoimmunity following checkpoint blockade therapy$467,621
R01 · FY2019 · CA
Promoting the Development of Epigenetically and Functionally Distinct Plasma Cell Populations by Modulating the Cytokine Microenvironment$382,913
P01 · FY2019 · AI · contact PI
Regulation of Pathogenic Plasma Cells in Human SLE$376,755
P01 · FY2019 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$352,555
R37 · FY2019 · AI · contact PI
ACE Funds Management Core$222,673
U19 · FY2019 · AI · contact PI
Principal Project$148,446
U19 · FY2019 · AI · contact PI
Core A - Administrative Core$80,777
P01 · FY2019 · AI · contact PI
Plasma Cells in Health and Disease$2,027,087
P01 · FY2018 · AI · contact PI
B cell Autoimmunity in Human SLE$435,020
U19 · FY2018 · AI · contact PI
Regulation of Pathogenic Plasma Cells in Human SLE$392,827
P01 · FY2018 · AI · contact PI
Promoting the Development of Epigenetically and Functionally Distinct Plasma Cell Populations by Modulating the Cytokine Microenvironment$368,941
P01 · FY2018 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$352,555
R37 · FY2018 · AI · contact PI
Core A - Administrative Core$78,186
P01 · FY2018 · AI · contact PI
Administrative Core$47,435
U19 · FY2018 · AI · contact PI
Plasma Cells in Health and Disease$2,027,642
P01 · FY2017 · AI · contact PI
B cell Autoimmunity in Human SLE$443,684
U19 · FY2017 · AI · contact PI
Regulation of Pathogenic Plasma Cells in Human SLE$392,825
P01 · FY2017 · AI · contact PI
Promoting the Development of Epigenetically and Functionally Distinct Plasma Cell Populations by Modulating the Cytokine Microenvironment$368,940
P01 · FY2017 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$362,695
R37 · FY2017 · AI · contact PI
Core A - Administrative Core$78,188
P01 · FY2017 · AI · contact PI
Administrative Core$46,307
U19 · FY2017 · AI · contact PI
Plasma Cells in Health and Disease$2,084,461
P01 · FY2016 · AI · contact PI
Promoting the Development of Epigenetically and Functionally Distinct Plasma Cell Populations by Modulating the Cytokine Microenvironment$515,953
P01 · FY2016 · AI · contact PI
B cell Autoimmunity in Human SLE$452,097
U19 · FY2016 · AI · contact PI
B cells in human SLE$407,403
U19 · FY2016 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$378,295
R37 · FY2016 · AI · contact PI
Regulation of Pathogenic Plasma Cells in Human SLE$368,606
P01 · FY2016 · AI · contact PI
Core A - Administrative Core$69,977
P01 · FY2016 · AI · contact PI
Administrative Core$44,694
U19 · FY2016 · AI · contact PI
B cell Autoimmunity in Human SLE$462,758
U19 · FY2015 · AI · contact PI
B cells in human SLE$394,625
U19 · FY2015 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$389,215
R37 · FY2015 · AI · contact PI
Administrative Core$68,133
U19 · FY2015 · AI · contact PI
B Cells in Health and Disease$2,188,962
P01 · FY2014 · AI · contact PI
B cell Autoimmunity in Human SLE$548,689
U19 · FY2014 · AI · contact PI
B cells in human SLE$386,111
U19 · FY2014 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$386,100
R37 · FY2014 · AI · contact PI
Human Effector B Cells: Homeostasis, Function and Regulation in SLE$311,834
P01 · FY2014 · AI · contact PI
Administrative Core$178,242
P01 · FY2014 · AI · contact PI
Administrative Core$84,578
U19 · FY2014 · AI · contact PI
B Cells in Health and Disease$2,056,593
P01 · FY2013 · AI · contact PI
Understanding the Generation of HIV Broadly Neutralizing Antibodies$674,331
R01 · FY2013 · AI · contact PI
Human Effector B Cells: Homeostasis, Function and Regulation in SLE$422,171
P01 · FY2013 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$362,934
R37 · FY2013 · AI · contact PI
Translational Research Project Effector and Regulatory B cells in SLE$254,081
U19 · FY2013 · AI · contact PI
Administrative Core$162,570
P01 · FY2013 · AI · contact PI
B Cells in Health and Disease$2,204,218
P01 · FY2012 · AI · contact PI
Understanding the Generation of HIV Broadly Neutralizing Antibodies$524,310
R01 · FY2012 · AI · contact PI
Human Effector B Cells: Homeostasis, Function and Regulation in SLE$304,604
P01 · FY2012 · AI · contact PI
Translational Research Project Effector and Regulatory B cells in SLE$284,124
U19 · FY2012 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$264,026
R37 · FY2012 · AI · contact PI
Administrative Core$169,768
P01 · FY2012 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$120,152
R37 · FY2012 · AI · contact PI
B Cells in Health and Disease$2,162,767
P01 · FY2011 · AI · contact PI
Autoimmunity Center of Excellence - Rochester$667,941
U19 · FY2011 · AI · contact PI
Understanding the Generation of HIV Broadly Neutralizing Antibodies$440,713
R01 · FY2011 · AI · contact PI
Human Effector B Cells: Homeostasis, Function and Regulation in SLE$402,187
P01 · FY2011 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$380,840
R37 · FY2011 · AI · contact PI
Translational Research Project Effector and Regulatory B cells in SLE$209,851
U19 · FY2011 · AI · contact PI
Administrative Core$185,144
P01 · FY2011 · AI · contact PI
Administrative Core$119,306
U19 · FY2011 · AI · contact PI
Understanding the Generation of HIV Broadly Neutralizing Antibodies$84,405
R01 · FY2011 · AI · contact PI
B Cells in Health and Disease$2,198,492
P01 · FY2010 · AI · contact PI
Autoimmunity Center of Excellence - Rochester$682,356
U19 · FY2010 · AI · contact PI
Identification of Biomarkers in Sjogren's Syndrome$604,182
R01 · FY2010 · DE · contact PI
Understanding the Generation of HIV Broadly Neutralizing Antibodies$530,142
R01 · FY2010 · AI · contact PI
Understanding the Generation of HIV Broadly Neutralizing Antibodies$414,803
R01 · FY2010 · AI · contact PI
Human Effector B Cells: Homeostasis, Function and Regulation in SLE$394,979
P01 · FY2010 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$383,541
R37 · FY2010 · AI · contact PI
Translational Research Project Effector and Regulatory B cells in SLE$214,691
U19 · FY2010 · AI · contact PI
Administrative Core$179,971
P01 · FY2010 · AI · contact PI
Administrative Core$121,536
U19 · FY2010 · AI · contact PI
Autoimmunity Center of Excellence - Rochester$1,290,000
U19 · FY2009 · AI · contact PI
Autoimmunity Center of Excellence - Rochester$693,000
U19 · FY2009 · AI · contact PI
Autoimmunity Center of Excellence - Rochester$600,601
U19 · FY2009 · AI · contact PI
Identification of Biomarkers in Sjogren's Syndrome$592,510
R01 · FY2009 · DE · contact PI
Understanding the Generation of HIV Broadly Neutralizing Antibodies$538,412
R01 · FY2009 · AI · contact PI
A Model System for the Study of Human B-cell Tolerance$384,595
R56 · FY2009 · AI · contact PI
Cellular Origins of HIV Broadly Neutralizing Antibodies$305,316
R21 · FY2009 · AI · contact PI
Translational Research Project Effector and Regulatory B cells in SLE$217,794
U19 · FY2009 · AI · contact PI
Administrative Core$123,706
U19 · FY2009 · AI · contact PI
Identification of Biomarkers in Sjogren's Syndrome$575,258
R01 · FY2008 · DE · contact PI
Cellular Origins of HIV Broadly Neutralizing Antibodies$229,650
R21 · FY2008 · AI · contact PI
Suppression and Exacerbation of B and T cell Responses *$827,584
U19 · FY2007 · AI · contact PI
Identification of Biomarkers in Sjogren's Syndrome$564,690
R01 · FY2007 · DE · contact PI
A Model System for the Study of Human B-cell Tolerance$298,677
R01 · FY2007 · AI · contact PI
Suppression and Exacerbation of B and T cell Responses *$828,438
U19 · FY2006 · AI · contact PI
Identification of Biomarkers in Sjogren's Syndrome$564,644
R01 · FY2006 · DE · contact PI
A Model System for the Study of Human B-cell Tolerance$307,598
R01 · FY2006 · AI · contact PI
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050029$0
N01 · FY2006 · AI · contact PI
Suppression and Exacerbation of B and T cell Responses *$824,647
U19 · FY2005 · AI
A Model System for the Study of Human B-cell Tolerance$315,000
R01 · FY2005 · AI
Study of Human B-cell Tolerance by Functional Genomics$236,250
R21 · FY2005 · AI
Suppression and Exacerbation of B and T cell Responses *$801,577
U19 · FY2004 · AI
A Model System for the Study of Human B-cell Tolerance$315,000
R01 · FY2004 · AI
Study of Human B-cell Tolerance by Functional Genomics$236,250
R21 · FY2004 · AI
Suppression and Exacerbation of B and T cell Responses *$408,130
U19 · FY2003 · AI
A Model System for the Study of Human B-cell Tolerance$315,000
R01 · FY2003 · AI
TRAINING IN IMMUNOLOGY AND INFECTIOUS DISEASES$204,660
T32 · FY2001 · AI
GENETIC AND FUNCTIONAL STUDY OF HUMAN CDR3 REGIONS$235,390
R01 · FY2000 · AG
TRAINING IN IMMUNOLOGY AND INFECTIOUS DISEASES$184,541
T32 · FY2000 · AI